May 14 (Reuters)-
Daiken Medical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2021 Mar 31, 2020 Mar 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 7.86 8.52 9.00 4.35
(-7.8 pct) (+1.4 pct) (+14.5 pct) (+15.3 pct)
Operating 921 mln 1.19 1.20 510 mln
(-22.9 pct) (-4.4 pct) (+30.3 pct) (+12.7 pct)
Recurring 957 mln 1.21 1.20 510 mln
(-20.9 pct) (-2.9 pct) (+25.4 pct) (+4.3 pct)
Net 675 mln 859 mln 840 mln 360 mln
(-21.4 pct) (+0.9 pct) (+24.4 pct) (+2.7 pct)
EPS 23.50 yen 29.92 yen 29.24 yen 12.53 yen
Ann Div 20.00 yen 20.00 yen 20.00 yen
-Q2 Div 9.00 yen 9.00 yen 9.00 yen
-Q4 Div 11.00 yen 11.00 yen 11.00 yen
NOTE - Daiken Medical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7775.T